The company has been awarded the very competitive PHASE 1 of the SME Instrument belonging to the Horizon 2020 of the European Union. Only the most innovative companies with the greatest social impact obtain this prestigious financing.

CORNEA_ project signs with the University of Santiago de Compostela and the Gallego de Saúde Service (Sergas) a licence agreement for the exclusive exploitation of the patent application “Biomarkers for diagnosis and prognosis of corneal ectasia”. Application number: EP 15382060
John Frantzis enters CORNEA_ project as a partner